Group 6 Copy 43
0
References
  • 1. Roberts, NA, Adams, BD, McCarthy, NI, Tooze, RM, Parnell, SM, Anderson, G, … Horsley, V. (2017). Prdm1 Regulates Thymic Epithelial Function To Prevent Autoimmunity. The Journal of Immunology, 199(4), 1250–1260. doi:10.4049/jimmunol.1600941
  • 2. Singh, T, and Adams, BD. (2017). The Regulatory Role of miRNAs on VDR in Breast Cancer. Transcription, 8(4), 232–241. DOI:10.1080/21541264.2017.1317695
  • 3. Chua FY, and Adams BD. (2017). Androgen Receptor and miR-206 Regulation in Prostate Cancer. Transcription, e1322668. DOI: 10.1080/21541264.2017.1322668
  • 4. Metheetrairut, C, Adams, BD, Nallur, S, Weidhaas, J, and Slack, FJ. (2016) cel-mir-237 and its Homologue, hsa-miR-125b, Modulate the Cellular Response to Ionizing Radiation. Oncogene, 36(4), 512-524. DOI: 10.1038/onc.2016.222
  • 5. Adams, BD, Parsons, C, Walker, L, Zhang, WC, and Slack, FJ. (2017) Targeting Noncoding RNAs in Disease. Journal Clinical Investigation, 127(3), 761-771. DOI: 10.1172/JCI84424
  • 6. Adams, BD, Wali, VB, Cheng, CJ, Inukai, S, Booth, CJ, Agarwal, S, Rimm, DL, Győrffy, B, Santarpia, L, Pusztai, L, Saltzman, WM, and Slack FJ. (2016) miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple Negative Breast Cancer. Cancer Research, 76(4), 927-939. DOI: 10.1158/0008-5472.CAN-15-2321
  • 7. Adams, BD, Parsons, C, and Slack, FJ. (2016). The Tumor-Suppressive and Potential Therapeutic Functions of miR-34a in Epithelial Carcinomas. Expert Opinion Therapeutic Targets, 20(6), 737-753. DOI: 10.1517/14728222.2016.1114102
  • 8. Adams, BD, Anastasiadou, E, Esteller, M, He, L, & Slack, FJ. (2015). The Inescapable Influence of Noncoding RNAs in Cancer. Cancer Research, 75(24), 5206-5210. DOI:10.1158/0008-5472.can-15-1989
  • 9. Gonzalez-Martin, A, Adams, BD, Lai, M, Shepherd, J, Salvador-Bernaldez, M, Salvador, JM, Lu, J, Nemazee, D, Xiao, C. (2016). The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nature Immunology, 17(4), 433-440. DOI: 10.1038/ni.3385
    Please wait...

    About This Project

    The treatments available for glioblastoma multiform (GBM) patients provide a minimal survival benefit, and novel methodologies to detect and treat GBM are needed. This project focuses on a gene product called noncoding RNA, a molecule that regulates the expression of tumor-causing genes at the RNA level. The Institute identified novel RNA transcripts detectable in human cancer. We will determine the consequences when cells lose these transcripts and will develop noncoding RNA biomarkers for GBM.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    A Bird's-eye View of Frog Habitats: Using a Drone to Survey Wetlands

    I study vulnerable frog species that inhabit human-constructed wetlands in the Grand River Grasslands of...

    CRISPR Capsules: Packaging Cas9 with bacterial outer membrane vesicles

    NU iGEM is creating a delivery system for an innovative antibiotic method centered around CRISPR, a powerful...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Backer Badge Funded